YZYing Zhao

Ying Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ying Zhao has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The value of diffusion kurtosis imaging texture analysis in predicting treatment response to transcatheter arterial chemoembolization in HCC

    by Chen Qiao, Ailian Liu, Ying Zhao, Qingwei Song, Xin Li, Yan Guo, Tingfan Wu

    This work aimed at texture analysis based on mean apparent diffusion coefficient (MD) of diffusion kurtosis imaging (DKI) to evaluate the treatment efficacy of transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The results showed that MD texture features can differentiate objective response and non-response groups. When using the single parameter, the GreyLevelNonuniformity_angle135_offset1 achieved the best result (AUC: 0.714, sensitivity: 68.2%, specificity: 81%). In the combined diagnosis of multiple parameters, FrequencySize,MaxIntensity, GreyLevelNonuniformity_angle0_offset1 and GreyLevelNonuniformity_angle135_offset1 were combined to obtain the best combined diagnosis(AUC:0.760,sensitivity: 81.8%, specificity: 66.7%).

  • Open Access

    Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy

    by Ying Zhao, Jingjun Wu, Qinhe Zhang, Zhengyu Hua, Wenjing Qi, Nan Wang, Tao Lin, Liuji Sheng, Dahua Cui, Jinghong Liu, et al.


  • Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy

    by Ying Zhao, Jingjun Wu, Qinhe Zhang, Zhengyu Hua, Wenjing Qi, Nan Wang, Tao Lin, Liuji Sheng, Dahua Cui, Jinghong Liu, et al.

    Background: Preoperative prediction of early recurrence (ER) of hepatocellular carcinoma (HCC) plays a critical role in individualized risk stratification and further treatment guidance.Purpose: To investigate the role of radiomics analysis based on multiparametric MRI (mpMRI) for predicting ER in HCC after partial hepatectomy.Study Type: Retrospective.Population: In all, 113 HCC patients (ER, n = 58 vs. non‐ER, n = 55), divided into training (n = 78) and validation (n = 35) cohorts.Field Strength/Sequence: 1.5T or 3.0T, gradient‐recalled‐echo in‐phase T1‐weighted imaging (I‐T1WI) and opposed‐phase T1WI (O‐T1WI), fast spin‐echo T2‐weighted imaging (T2WI), spin‐echo planar diffusion‐weighted imaging (DWI), and gradient‐recalled‐echo contrast‐enhanced MRI (CE‐MRI).Assessment: In all, 1146 radiomics features were extracted from each image sequence, and radiomics models based on each sequence and their combination were established via multivariate logistic regression analysis. The clinicopathologic‐radiologic (CPR) model and the combined model integrating the radiomics score with the CPR risk factors were constructed. A nomogram based on the combined model was established.Statistical Tests: Receiver operating characteristic (ROC) curve analysis was used to evaluate the discriminative performance of each model. The potential clinical usefulness was evaluated by decision curve analysis (DCA).Results: The radiomics model based on I‐T1WI, O‐T1WI, T2WI, and CE‐MRI sequences presented the best performance among all radiomics models with an area under the ROC curve (AUC) of 0.771 (95% confidence interval (CI): 0.598–0.894) in the validation cohort. The combined nomogram (AUC: 0.873; 95% CI: 0.756–0.989) outperformed the radiomics model and the CPR model (AUC: 0.742; 95% CI: 0.577–0.907). DCA demonstrated that the combined nomogram was clinically useful.Data Conclusion: The mpMRI‐based radiomics analysis has potential to predict ER of HCC patients after hepatectomy, which could enhance risk stratification and provide support for individualized treatment planning.Evidence Level: 4.Technical Efficacy: Stage 4.